Xbrane Biopharma AB (XBRANE) — Cash Flow Quality Index

Latest as of June 2025: -0.38x

Xbrane Biopharma AB (XBRANE) has a Cash Flow Quality Index of -0.38x as of June 2025. Operating cash flow of Skr-65.06 Million is below net income of Skr171.81 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Xbrane Biopharma AB cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-0.38x

Operating CF / Net Income

Operating Cash Flow

Skr-65.06 Million

SEK

Net Income

Skr171.81 Million

SEK

Data as of

Jun 2025

Most recent filing

Annual Cash Flow Quality Index for Xbrane Biopharma AB (None–None)

Year-by-year earnings quality comparison for Xbrane Biopharma AB.

Year	Quality Index	Operating CF (SEK)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.